Vistry sales improve – should you buy into the boom?
Housebuilder Vistry’s unusual business model has fuelled rapid sales growth amid a sluggish private sales market
Most people in the UK agree that something needs to be done to improve access to housing. With house prices so high that people have to save well into their thirties to get on to the property ladder, some experts estimate that as many as three million homes will need to be built to achieve other countries’ levels of affordability.
The new government has made clear that building more houses will be a priority, with the chancellor outlining major changes to the planning rules, along with a national building target for 1.5 million homes a year for at least the next five years.
Is Vistry a worthwhile investment?
All this is good news for house builders such as Vistry (LSE: VTY). While many firms in the sector have been accused of hoarding land without building on it, Vistry has steadily been moving to a “partnerships” business model. In the past, developers would design a project, get approval and then build the houses, before trying to sell them.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
While this enables the builder to reap the rewards of the investment, it can take a long time, and involves putting a lot of money upfront. By contrast, Vistry gets housing associations and local authorities both to commit to projects before building work starts, and to put up much of the cost.
Such a strategy is not without its drawbacks. It means that Vistry gets less for each house or block of flats that it sells than if it sold them in the usual way. However, it comes with several key benefits. First, getting the buyers to put money down in advance means that Vistry doesn’t have to tie up large amounts of working capital, and the money can instead be invested in other projects. It also makes securing planning approval much easier, as the group can show that its partners are committed to the project.
This has enabled Vistry to grow at an explosive rate, with revenue tripling between 2018 and 2023. This isn’t just a flash in the pan. Vistry has a huge, £5.2 billion backlog of projects in the pipeline, which should keep growing now that the new government sees house building as a priority. Earnings per share have been more variable, but they are now rising consistently.
Despite this, Vistry is still attractively valued, trading at only 12.5 times 2025 earnings and yielding 4.4%. The company has also done well enough to launch a £100 million share-buyback programme, which is due to end in September.
Vistry’s shares have plenty of momentum. According to investment platform AJ Bell, Vistry was one of the best-performing stocks in the FTSE 100 in the first six months of 2024. It has doubled since October, and is still trading above its 50-day and 200-day moving averages. I suggest going long at the current price of 1,317p at £1.50 a share. Put the stop-loss at 717p, which gives you a total downside of £900.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

-
The UK areas which saw biggest jump in asking prices in 2025 – is yours on the list?We look at the UK areas where asking prices rose the most last year.
-
‘Sandwich generation’ carers losing £6,000 a year to support elderly relativesMiddle-aged adults are often caught between caring for children or grandchildren and their elderly parents, leaving them taking time out of the workforce and facing a huge hit to wages while they are still trying to save for retirement. We look at the true cost of caring.
-
Three promising emerging-market stocks to diversify your portfolioOpinion Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money
-
Coface offers excess profit in an unloved sectorCoface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Exciting opportunities in biotechBiotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
How to invest in the new breed of payment providersUpstart payment providers are taking the world by storm. It’s time for investors to buy in, says Rupert Hargreaves
-
What turns a stock market crash into a financial crisis?Opinion Professor Linda Yueh's popular book on major stock market crashes misses key lessons, says Max King
-
How to add cryptocurrency to your portfolioA new listing shows how bitcoin might add value to a portfolio if cryptocurrency keeps gaining acceptance, says Cris Sholto Heaton
-
Profit from pest control with Rentokil InitialRentokil Initial is set for global expansion and offers strong sales growth
-
Three funds to buy for capital growth and global incomeOpinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust